http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100353260-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 |
filingDate | 1999-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2002-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2002-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-100353260-B1 |
titleOfInvention | A triple fusion genes carrying drug resistance gene, green fluorescent protein gene and drug-sensitizing gene and gene expression vector harboring the gene |
abstract | The present invention relates to a triple fusion gene carrying a drug resistant gene, a green fluorescent protein gene and a thymidine kinase gene, and a gene expression vector comprising the same. According to the present invention, positive expression, in vivo, is expressed by expressing one gene. It is also possible to perform both negative selection and monitoring of the fate or gene expression of transformed cells in vitro. |
priorityDate | 1999-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 450.